| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3401 | |||||||||||||||||||||||
| Submitter : | Mr. joseph wassong | Date & Time: | 12/18/2006 09:12:36 | |||||||||||||||||||||
| Organization : | Mr. joseph wassong | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| We will promote companies that do not use aborted fetal cell lines. We will boycott those that do. | ||||||||||||||||||||||||